A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas
Age: 18 years - 66+
Gender: All
We've found 1 total result for "Lymphoproliferative Disorders".
We've found 1 total result for "Lymphoproliferative Disorders".
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas
Age: 18 years - 66+
Gender: All